Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

The RealReal's Return On Capital Employed Overview

According to Benzinga Pro data, during Q4, The RealReal (NASDAQ:REAL) posted sales of $145.12 million. Earnings were up 8.74%, but The RealReal still reported an overall loss of $52.20 million.

Benzinga

Garrett Motion's Return on Invested Capital Overview

Pulled from Benzinga Pro data, Garrett Motion (NASDAQ:GTX) showed a loss in earnings since Q4, totaling $88.00 million. Sales, on the other hand, increased by 4.52% to $901.00 million during Q1.

Benzinga

Ultralife's Return On Capital Employed Overview

According to data from Benzinga Pro, during Q1, Ultralife's (NASDAQ:ULBI) reported sales totaled $30.37 million. Despite a 85.73% increase in earnings, the company posted a loss of $161.00 thousand.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Looking Into West Bancorp's Return On Capital Employed

According to Benzinga Pro, during Q1, West Bancorp (NASDAQ:WTBA) earned $13.18 million, a 10.7% increase from the preceding quarter. West Bancorp's sales decreased to $26.22 million, a 2.72% change since Q4.

Benzinga

Option Care Health's Return On Capital Employed Overview

According to Benzinga Pro, during Q1, Option Care Health (NASDAQ:OPCH) earned $30.27 million, a 59.88% increase from the preceding quarter. Option Care Health's sales decreased to $915.78 million, a 1.23% change since Q4.

Benzinga

ChipMOS Clocks 4% Revenue Growth in Q1; Margin Expands Amid Inflation, Supply Chain Woes

ChipMOS TECHNOLOGIES INC (NASDAQ:IMOS) reported first-quarter FY22 revenue growth of 4% year-on-year to $235 million. Revenue decreased by 1% Q/Q. The gross margin expanded 80 bps amid global inflation and supply chain constraints. Net non-operating income was $8 million versus $0.9 million a year ago. Earnings per basic ADS were $1.18 versus $0.92…

Benzinga

Lawson Products's Return on Invested Capital Overview

According to Benzinga Pro, during Q1, Lawson Products (NASDAQ:LAWS) earned $8.99 million, a 1250.58% increase from the preceding quarter. Lawson Products also posted a total of $117.88 million in sales, a 15.49% increase since Q4.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

American Electric Power's Return On Capital Employed Insights

According to Benzinga Pro, during Q1, American Electric Power (NASDAQ:AEP) earned $718.10 million, a 33.33% increase from the preceding quarter. American Electric Power also posted a total of $4.60 billion in sales, a 12.2% increase since Q4.

Benzinga

Keurig Dr Pepper's Return on Invested Capital Overview

According to Benzinga Pro, during Q1, Keurig Dr Pepper (NASDAQ:KDP) earned $585.00 million, a 30.6% increase from the preceding quarter. Keurig Dr Pepper's sales decreased to $3.08 billion, a 9.23% change since Q4.

Benzinga

Power Integrations's Return on Invested Capital Overview

According to Benzinga Pro, during Q1, Power Integrations (NASDAQ:POWI) earned $46.25 million, a 13.63% increase from the preceding quarter. Power Integrations also posted a total of $182.15 million in sales, a 5.5% increase since Q4.

Benzinga

Pegasystems's Return on Invested Capital Insights

According to data from Benzinga Pro, during Q1, Pegasystems's (NASDAQ:PEGA) reported sales totaled $376.31 million. Despite a 98.98% increase in earnings, the company posted a loss of $379.00 thousand.

Benzinga

DexCom Earnings Perspective: Return On Invested Capital

Pulled from Benzinga Pro data, DexCom (NASDAQ:DXCM) posted Q1 earnings of $97.30 million, an increase from Q4 of 601.55%. Sales dropped to $628.80 million, a 9.94% decrease between quarters.

Benzinga

Looking Into NovoCure's Return On Capital Employed

According to data from Benzinga Pro, during Q1, NovoCure's (NASDAQ:NVCR) reported sales totaled $137.55 million. Despite a 82.44% increase in earnings, the company posted a loss of $4.65 million.

Benzinga

Alnylam Pharmaceuticals Earnings Perspective: Return On Capital Employed

According to data from Benzinga Pro, during Q1, Alnylam Pharmaceuticals's (NASDAQ:ALNY) reported sales totaled $213.26 million. Despite a 7.01% increase in earnings, the company posted a loss of $240.34 million.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Recap: Selecta Biosciences Q1 Earnings

Selecta Biosciences (NASDAQ:SELB) reported its Q1 earnings results on Thursday, May 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Shenandoah's Return On Capital Employed Insights

Benzinga Pro data, Shenandoah (NASDAQ:SHEN) reported Q1 sales of $64.41 million. Earnings fell to a loss of $603.00 thousand, resulting in a 172.65% decrease from last quarter.

Benzinga

Inari Medical Q1 Earnings Beat Street View, Lifts FY22 Sales Outlook Above Consensus

Inari Medical Inc's (NASDAQ:NARI) Q1 revenue was $86.8 million, up 4% sequentially and 51% Y/Y, beating the consensus of $83.61 million. The increase over the prior year was driven by continued U.S. commercial expansion and new product introductions. The gross margin was 88.5% compared to 91.9% a year ago, modestly lower primarily…

Benzinga

Mercer International's Return On Capital Employed Insights

According to Benzinga Pro, during Q1, Mercer International (NASDAQ:MERC) earned $88.90 million, a 19.29% increase from the preceding quarter. Mercer International also posted a total of $592.74 million in sales, a 14.22% increase since Q4.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

VeriSign's Return on Invested Capital Overview

According to Benzinga Pro data VeriSign (NASDAQ:VRSN) posted a 52.28% decrease in earnings from Q4. Sales, however, increased by 1.94% over the previous quarter to $346.90 million.

Benzinga

New Fortress Energy: Q1 Earnings Insights

New Fortress Energy (NASDAQ:NFE) reported its Q1 earnings results on Thursday, May 5, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Benzinga

Quidel Clocks More Than Three-Fold Jump In COVID-19 Products

Quidel Corp's (NASDAQ:QDEL) Q1 sales more than doubled to $1 billion, beating the consensus of $890 million and meeting management expectations. The company attributed the increase to significantly increased sales of rapid immunoassay products, specifically QuickVue At-Home OTC COVID-19 tests, Sofia Influenza + SARS, and Sofia Influenza tests. "Our diverse suite of assays,…

Benzinga

Consolidated Comms Hldgs: Q1 Earnings Insights

Consolidated Comms Hldgs (NASDAQ:CNSL) reported its Q1 earnings results on Thursday, May 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Pacific Biosciences Clocks 14% Jump In Q1 Revenues

Pacific Biosciences of California Inc's (NASDAQ:PACB) Q1 sales increased 14% Y/Y to $33.2 million, driven by sales of instruments and consumables and beating the consensus of $32.82 million. Instrument revenue was $15.6 million, compared with $14.9 million a year ago. Consumables revenue was $12.7 million, up from $10.4 million in Q1 2021.…

Benzinga

Hycroft Mining Holding Corporation (NASDAQ: HYMC) shares are trading higher by 27.92% at $1.79 after the company reported first-quarter earnings results.

Benzinga

Papa John's Q1 Earnings Exceed Expectations

Papa John's International Inc (NASDAQ:PZZA) reported first-quarter FY22 sales growth of 6% year-on-year to $542.69 million, beating the consensus of $540.39 million. Adjusted EPS of $0.95 topped the Street view of $0.94. Total comparable sales growth was 1.6% versus 25.4% the prior year. Comparable sales improved 1.9% in North America and 0.8% Internationally.…

1 … 477 478 479 480

Organisations

Alnylam Pharmaceuticals

28 stories

American Electric Power

ChipMOS TECHNOLOGIES Inc

17 stories

Option Care Health

17 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.